Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
Get this in your inbox everyday by subscribing to our newsletters.
5. Smart patch monitors blood, releases blood thinners to prevent clots
Researchers from the North Carolina State University and the University of North Carolina at Chapel Hill have developed a patch designed to monitor a patient’s blood and release blood-thinning drugs to prevent dangerous blood clots, or thrombosis. The team’s work was published in Advanced Materials.
When blood clots disrupt the flow of blood throughout the body, the result can cause pulmonary embolism, heart attack or stroke. Conventional treatment requires patients to regularly test their blood to ensure proper dosages of blood thinners such as Heparin. Read more
4. Moximed launches IDE trial of Atlas unicompartmental knee
California orthopedic device developer Moximed said today it enrolled the 1st patient in an FDA approved investigational device exemption trial of its next-gen Atlas unicompartmental unloading knee implant.
The Atlas is designed to treat osteoarthritis knee joint pain in patients ages 35 to 65 whose condition has not degenerated enough to require arthroplasty. The device is a joint unloader placed along the knee to absorb excess load and buy time. Read more
3. NeuroMetrix wins CE Mark for Quell wearable pain relief device
NeuroMetrix said today it won CE Mark approval in the European Union for its Quell wearable pain relief device, now cleared as a class IIa medical device in the region.
The Waltham, Mass.-based company said that recent studies indicate that 20-40% of the adult European population suffers from chronic pain, which costs the region approximately $250 billion annually. NeuroMetrix’s Quell is designed to treat chronic pain, which can help improve sleep, mental and general health. Read more
2. Becton Dickinson to shutter Creedmoor, N.C. plant, lay off 120
Becton Dickinson & Co. is reportedly shutting down its Creedmoor, N.C. plant and laying off the 120 workers that operate out of it, according to The News & Observer.
The facility in Creedmoor produces tubing for intravenous pumps, according to the report. The production at the facility will be consolidated to existing facilities, with assembly jobs moving to Tijuana and Nogales, Mexico, while molding work will move to Sandy, Utah. Read more
1. Anonymous strategic investor puts another $5m into Endonovo’s Immunotronics
Endonovo Therapeutics said this week that it inked a $5 million deal with an anonymous strategic investor aimed at retiring its convertible debt, launching pre-clinical studies of its Immunotronics platform and uplisting its shares.
The Los Angeles-based company, which is developing technology it calls “Immunotronics” to stimulate liver regeneration and treat inflammatory conditions, said it plans to use the proceeds in part to buy back some $2.2 million worth of convertible debt. Its backer is the same entity that’s the lead investor in a previously announced financing worth $10 million, Endonovo said. Read more
The post MassDevice.com +5 | The top 5 medtech stories for November 30, 2016 appeared first on MassDevice.
from MassDevice http://ift.tt/2gJDdqe
Cap comentari:
Publica un comentari a l'entrada